Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Health Reference Charts
Type 1 Issues Archives
Print | Email | Share | Comments (5)

“Reprogrammed” Cells in Mice Reverse Late-stage Type 1 Diabetes


May 15, 2012

A successful experiment on mice with type 1 diabetes, which involved "reprogramming" their immune systems to stop attacks on pancreatic beta cells, may point the way to an eventual cure for the disease in humans.

The experiment, led by the City of Hope medical research center in Duarte, California, first used antibodies to kill the two kinds of cells that are involved in autoimmune attacks against insulin-producing beta cells in the pancreas. In type 1 diabetes, the cells that defend the body against bacteria, viruses, and outside intruders erroneously attack the beta cells, eventually destroying them and the body's ability to produce insulin.

Once the defender cells were killed, the researchers transplanted bone marrow into the mice to restore the cells. The new immune cells from the marrow no longer carried the factor that made the previous cells attack the pancreas's insulin-making beta cells. In short, the new cells left the mice's pancreases alone.

At the same time, the researchers injected the diabetic mice with pancreas growth factor, which led to the creation of new insulin-producing beta cells. The cessation of autoimmune attacks, combined with a restored ability to produce insulin, led to a virtual cure of the mice's disease.

Two aspects of the study give rise to high hopes for its treatment approach. First, it involved mice that had late-stage type 1 diabetes. Second, it combined cell replacement and pancreatic growth factor, two therapies that are not new but had not been combined before.

As promising as the City of Hope approach is, it will be several years before it can be used experimentally on humans. The next step will be to try the treatment on primates, which are physiologically closer to humans than mice are.  

The study, funded by the Iacocca Family Foundation and private donations, was published in Science Translational Medicine.


Categories: Diabetes, Diabetes, Diabetes Health, Insulin, Pancreas, Pancreatic Beta Cells, Research, Science Translational Medicine, Type 1, Type 1 Diabetes, Type 1 Issues



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 5 comments - May 15, 2012

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.